Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Cancer remains a leading cause of death globally, with treatment efficacy limited by poor selectivity and resistance.
• Genomic instability, a cancer hallmark, arises from DNA damage, which can be exacerbated by reactive oxygen and nitrogen species (ROS).
• The DNA damage response (DDR) network is crucial for repairing DNA lesions, but its dysregulation contributes to cancer progression and treatment resistance.

Purpose of the Study:

• To explore the intricate relationship between redox homeostasis and the DNA damage response (DDR) in cancer.
• To identify ROS-sensitive proteins within the DDR pathway as potential targets for novel anticancer strategies.
• To investigate the potential for tailored therapeutic interventions based on modulating ROS levels for selective cancer treatment.

Main Methods:

• Review and synthesis of existing literature on DNA damage, DDR pathways, and redox biology in cancer.
• Analysis of how reactive oxygen species (ROS) influence DDR signaling in both healthy and cancerous cells.
• Identification of key ROS-sensitive proteins involved in DDR pathways.

Main Results:

• Redox homeostasis significantly impacts DDR, with ROS playing a dual role in activating or inhibiting DDR proteins.
• Dysregulated DDR, influenced by ROS, can either promote genomic instability or confer resistance to cancer therapies.
• Specific ROS-sensitive proteins within the DDR pathway have been identified as potential targets for therapeutic manipulation.

Conclusions:

• Modulating ROS homeostasis presents a promising avenue for developing selective anticancer strategies.
• Targeting ROS-sensitive DDR proteins could lead to therapies better tailored to individual patient profiles.
• Further research into the interplay between ROS and DDR may unlock new combination treatments for cancer.